Synact
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
85 Fuller Ave, Webster, New York, 14580,...Phone Number
(585) 545-4903Website
www.synact.netRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Synact
SYNACT is a Microsoft Certified Partner that specializes in providing CRM solutions, particularly through Microsoft Dynamics 365 and Microsoft Teams. They focus on helping small to medium-sized businesses (SMBs) enhance their productivity and return on investment (ROI) with an all-inclusive support model that includes unlimited training and dedicated partnership. By streamlining business processes and offering tailored technology solutions, SYNACT aims to transform the way companies operate in the digital era. Their commitment to understanding client needs ensures that they deliver value and support for long-term success.Explore more
Synact Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Synact your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Synact is spiking on competitors!
Click to see if Synact had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Synact has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Synact has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Synact
Synact, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Synact launches new products
Earning: See what the market has to say on Synact recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Synact
Compare insights from companies similar to Synact, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Synact is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Synact is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Synact.
Synact Tech Stack
A closer look at the technologies used by Synact
Synact News & Media
BioStock: SynAct Pharma’s CEO comments on EXPAND data
SynAct Pharma has announced disappointing top-line data from its 12-week EXPAND phase IIb clinical trial. The study is evaluating the drug candidate resomelagon in newly diagnosed rheumatoid arthritis patients with severe disease. Results show a high placebo effect thus not achieving the primary endpoint – a statistically higher rate of 20 improvement in the American College of Rheumatology score compared to placebo. BioStock spoke to CEO Torbjørn Bjerke about the results. Read the full articleBioStock: SynAct Pharma’s CEO comments on the recent progress
SynAct Pharma recently achieved a milestone by completing dosing in the Phase IIb EXPAND study for resomelagon (AP1189), their candidate targeting rheumatoid arthritis. In addition, the company has now also successfully recruited all patients for part A of the Phase IIa/b RESOLVE study. To delve deeper into these developments, BioStock contacted SynAct Pharma’s CEO, Torbjørn Bjerke, for a comment. Read the full interview with Torbjørn Bjerke at biostock.se: https://www.biostock.se/en/2023/07/synSynAct announces outcome of rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE. On 28 March 2022, SynAct Pharma AB (“SynAct” or the “Company”) announcedSynAct publishes prospectus in connection with a fully guaranteed rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE. The Board of Directors of SynAct Pharma AB (”SynAct” or the “Company”)
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synact
Sign Up For FreeTo access detailed company insights
SYNACT is a Microsoft Certified Partner that specializes in providing CRM solutions, particularly through Microsoft Dynamics 365 and Microsoft Teams. They focus on helping small to medium-sized businesses (SMBs) enhance their productivity and return on investment (ROI) with an all-inclusive support model that includes unlimited training and dedicat... Read More
